News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provectus Pharmaceuticals Inc. Release: PV-10 Data on Locoregional Disease Control in Metastatic Melanoma to be Presented at European Cancer Congress 2013



6/24/2013 7:31:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Provectus Pharmaceuticals, Inc. (OTCQB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that an exploratory analysis of data on locoregional disease control in metastatic melanoma from its completed Phase 2 study of intralesional PV-10 has been accepted for presentation at the upcoming European Cancer Congress (ECCO 17- ESMO-38 - ESTRO 32), which will take place September 27 through October 1, 2013 in Amsterdam, The Netherlands.

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Read at BioSpace.com

Related News

comments powered by Disqus
   
Melanoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES